Other News

Moving Analytics Raises $20M to Scale Cardiovascular Telehealth Programs in Underserved Communities

IRVINE, Calif.–(BUSINESS WIRE)–Moving Analytics, the leading telehealth provider of cardiovascular prevention programs, today announced it has raised a $20 million Series A financing round. The round was co-led by Wellington Access Ventures and Seae Ventures with participation from Philips Ventures, SteelSky Ventures, Aphelion Capital, Nueterra Capital, and Citi Ventures. The new capital brings the […]

Medtronic announces co-promotion agreement with CathWorks, with path toward acquisition

  Partnership underscores Medtronic’s commitment to investing in innovative technologies that support physicians and patients from diagnosis to treatment CathWorks’ FFRangio® System provides diagnostic and physiologic information through artificial intelligence to potentially disrupt traditional FFR and revolutionize the management of coronary artery disease DUBLIN and KEFAR SAVA, Israel, July 12, 2022 /PRNewswire/ — Medtronic […]

Cerus Endovascular Names Stephen Griffin as Chief Executive Officer

FREMONT, Calif. and OXFORD, United Kingdom, July 12, 2022 /PRNewswire/ — Cerus Endovascular Ltd., a privately held, commercial-stage medical device company, announced today the appointment of Stephen Griffin, Ph.D. to Chief Executive Officer, effective immediately. Dr. Griffin has been with the company since 2014 and was appointed President in 2018. He was critical in assembling […]

Ancora Heart Receives Breakthrough Device Designation from FDA for the AccuCinch® Ventricular Restoration System

Designation Allows for Expedited Review of Transcatheter Therapy Designed to Improve Left Ventricular Structure and Function in Heart Failure Patients with Reduced Ejection Fraction SANTA CLARA, Calif.–(BUSINESS WIRE)–Ancora Heart, Inc., a company developing a novel device-based therapy to address heart failure, today announced that the U.S. Food and Drug Administration […]

Successful Heart Xenotransplant Experiments at NYU Langone Set Protocol for Pig-to-Human Organ Transplantation

NEW YORK, July 12, 2022 /PRNewswire/ — A team at NYU Langone Health successfully transplanted two genetically engineered pig hearts into recently deceased humans in June and July, marking the latest advances toward addressing the nationwide organ shortage and developing a clinical protocol that would provide an alternative supply of organs for […]

Philips spotlights latest AI-powered, software-defined MR smart systems at ECR 2022

July 12, 2022 Philips SmartSpeed AI-based software receives FDA 510(k) clearance, delivering breakthrough high-speed, high-resolution MR imaging Unique broad compatibility (97% of clinical protocols) allows faster and high-quality scans for virtually all patients with various conditions including those with implants Intelligent MR acceleration software helps drive increased MR department efficiency […]

Canon Medical Systems USA Inc. Announces Expansion of Distributorship with the Acquisition of NXC Imaging

Tustin, California, July 11, 2022 (GLOBE NEWSWIRE) — Canon Medical Systems USA Inc., a commercial subsidiary of Canon Medical Systems Corporation and a global leader in innovative diagnostic imaging technology, today announces it has signed a definitive agreement to acquire NXC Imaging, a medical imaging equipment distributor and service provider […]

New Access Vascular Retrospective Data Review Demonstrates Midline Catheters Composed of Advanced Biomaterials May Improve Dwell Times

Data also finds using materials that mimic the body’s chemistry leads to meaningful reductions in complications such as phlebitis, occlusion, and infections BILLERICA, Mass., July 12, 2022 (GLOBE NEWSWIRE) — Access Vascular, Inc. (AVI) today shared initial findings from a retrospective review of patient records that demonstrates an increase in dwell times […]

Nuwellis Initiates Its Outpatient Heart Failure Strategy Using Aquadex Ultrafiltration Therapy

MINNEAPOLIS, July 12, 2022 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage company focused on improving the quality of life for people with fluid overload, today announced key takeaways from its recent physician-led webinar discussing the benefits of treating fluid overloaded heart failure (HF) patients with Aquadex® ultrafiltration (UF) in the […]

scPharmaceuticals Inc. Announces Positive Results from the AT HOME-HF Phase 2 Pilot Study in Heart Failure

Study results favor FUROSCIX® versus “treatment as usual” in composite primary endpoint and all secondary endpoints FUROSCIX demonstrated an acceptable tolerability profile Company on track for Q4 2022 commercial launch of FUROSCIX, if approved BURLINGTON, Mass., July 12, 2022 (GLOBE NEWSWIRE) —  scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on […]